These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8472630)

  • 1. Immunoprotection in spontaneous remission of type 1 diabetes: long-term follow-up results.
    Yilmaz MT; Devrim AS; Biyal F; Satman I; Arioğlu E; Dinççag N; Karsidağ K; Ozden I; Gürel N; Sipahioğlu F
    Diabetes Res Clin Pract; 1993 Feb; 19(2):151-62. PubMed ID: 8472630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Lady-like": is there a latent autoimmune diabetes in the young?
    Lohmann T; Nietzschmann U; Kiess W
    Diabetes Care; 2000 Nov; 23(11):1707-8. PubMed ID: 11092301
    [No Abstract]   [Full Text] [Related]  

  • 5. Seven years of remission in a type I diabetic patient.
    Koivisto VA; Leirisalo-Repo M; Ebeling P; Tuominen JA; Knip M; Turunen U; Mandrup-Poulsen T; Pelkonen R
    Diabetes Care; 1993 Jul; 16(7):990-5. PubMed ID: 8359107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E; Dündar B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.
    Allen HF; Klingensmith GJ; Jensen P; Simoes E; Hayward A; Chase HP
    Diabetes Care; 1999 Oct; 22(10):1703-7. PubMed ID: 10526739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients.
    Agner T; Damm P; Binder C
    Diabetes Care; 1987; 10(2):164-9. PubMed ID: 3556104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus.
    Imagawa A; Hanafusa T; Itoh N; Waguri M; Yamamoto K; Miyagawa J; Moriwaki M; Yamagata K; Iwahashi H; Sada M; Tsuji T; Tamura S; Kawata S; Kuwajima M; Nakajima H; Namba M; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):574-8. PubMed ID: 10333050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient neonatal diabetes mellitus: a relapse after 10 years of complete remission.
    Vanelli M; De Fanti A; Cantoni S; Chiari G
    Acta Diabetol; 1994 Jun; 31(2):116-8. PubMed ID: 7949222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic and clinical characterization of slowly progressive IDDM.
    Kobayashi T; Tamemoto K; Nakanishi K; Kato N; Okubo M; Kajio H; Sugimoto T; Murase T; Kosaka K
    Diabetes Care; 1993 May; 16(5):780-8. PubMed ID: 8098691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial remission period in insulin-dependent diabetes in the young subject].
    Vague P; Vialettes B; Lassmann V; Moulin JP
    Diabete Metab; 1985 Jun; 11(3):181-8. PubMed ID: 3928412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes.
    Sobngwi E; Vexiau P; Levy V; Lepage V; Mauvais-Jarvis F; Leblanc H; Mbanya JC; Gautier JF
    Diabet Med; 2002 Oct; 19(10):832-5. PubMed ID: 12358870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.